Chemed Corporation is currently in a long term downtrend where the price is trading 0.9% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.7.
Chemed Corporation's total revenue rose by 2.1% to $533M since the same quarter in the previous year.
Its net income has increased by 73.5% to $114M since the same quarter in the previous year.
Finally, its free cash flow grew by 40.5% to $71M since the same quarter in the previous year.
Based on the above factors, Chemed Corporation gets an overall score of 4/5.
